Table 1 Descriptive characteristics of study population stratified by AKI
No AKI | AKI | p value | |
|---|---|---|---|
n | 61,746 | 2864 | |
Age, years, mean (SD) | 60.2 (18.0) | 70.7 (13.9) | < 0.001 |
Sex, Males, n (%) | 28,149 (45.6) | 1771 (61.8) | < 0.001 |
Charlson/Deyo score, n (%) | < 0.001 | ||
0 | 48,693 (78.9) | 1662 (58.0) | |
1 | 9190 (14.9) | 624 (21.8) | |
2 | 2199 (3.6) | 319 (11.1) | |
> 2 | 1664 (2.7) | 259 (9.0) | |
Charlson/Deyo score, mean (SD) | 0.3 (0.8) | 0.8 (1.1) | < 0.001 |
Comorbidity, n (%) | |||
Cardiovascular | 23,208 (37.6) | 1747 (61.0) | < 0.001 |
Gastrointestinal | 9487 (15.4) | 410 (14.3) | 0.134 |
Malignancies | 19,471 (31.5) | 758 (26.5) | < 0.001 |
Endocrine/Metabolic | 10,680 (17.3) | 702 (24.5) | < 0.001 |
Genito/Urinary | 6876 (11.1) | 782 (27.3) | < 0.001 |
Infectious | 3007 (4.9) | 269 (9.4) | < 0.001 |
Respiratory | 7580 (12.3) | 698 (24.4) | < 0.001 |
eGFR, ml/min/1.73m2,median (IQR)* | 82.0 (35.0) | 50.0 (43.0) | < 0.001 |